Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07738328 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Terbinafine for CSA-AKI Prevention

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Primary Objective: To evaluate the efficacy and safety of perioperative oral terbinafine in reducing the incidence of cardiac surgery-associated acute kidney injury (CSA-AKI).Secondary Objectives:To assess the effects of terbinafine on the severity of post-cardiac surgery AKI, length of hospital stay, and 30-day major adverse kidney events (MAKE30);To evaluate its impacts on biomarkers of renal injury and inflammation.
Trial Details
NCT Number NCT07738328
Lead Sponsor Guangdong Provincial People's Hospital
Conditions
(from sponsor)		 Acute Kidney Injury, Cardiac Surgical Procedures
Related terms Acute Kidney Injury
Enrollment 208 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov